previously medical experiments of CagriSema identified that it served people obtain drastically larger weight loss than semaglutide (Wegovy) did. even though Lilly's Zepbound/Mounjaro topples Wegovy, It is achievable that CagriSema could enter the industry at the right time for Novo Nordisk to keep its Total leadership during the weight problems dr